Ganesh Consumer Q1 FY27: PAT up 31% YoY to ₹12.5 Cr as margins expand, revenue dips 7%
PAT +31.37% YoY · revenue -7.1% · margins expanding
₹188.54 Cr
-7.1% YoY
₹12.52 Cr
+31.37% YoY
6.58%
+1.9pp YoY
₹3.14
Ganesh Consumer Products reported standalone PAT of ₹12.52 Cr for Q1 FY27, up 31.4% YoY from ₹9.53 Cr and up 31.3% QoQ, even as total income fell 6.8% YoY to ₹190.34 Cr (revenue from operations down 7.1% YoY to ₹188.54 Cr, -13.5% QoQ). EPS came in at ₹3.14 versus ₹2.62 a year ago and ₹2.37 in Q4 FY26. No analyst consensus estimates could be found for this stock — coverage remains thin roughly ten months after its September 2025 IPO — so vsStreet is marked unknown rather than guessed.
Q1 FY-2027 vs prior quarters
The profit growth was overwhelmingly a margin and finance-cost story, not a volume one. Net profit margin (PAT/total income) expanded to 6.58% from 4.67% a year ago and 4.33% in Q4 FY26; EBITDA margin, per management's own disclosure, rose to 11.2% from 10.49% YoY and 8.02% QoQ. Two levers drove this: finance costs collapsed 85% YoY to ₹0.57 Cr from ₹3.86 Cr after the company used ₹60 Cr of IPO proceeds to prepay borrowings — accounting for roughly ₹3.29 Cr of the ₹3.99 Cr YoY increase in PBT — and cost of materials consumed eased to 74.3% of revenue from 76.5% a year ago. Partly offsetting this, employee costs (2.10% of revenue vs 1.65%) and other expenses (15.2% vs 13.5%) rose as a share of a smaller revenue base, showing some fixed-cost drag from the topline decline.
The stock went into the print at ₹174, down 11.6% over the past month of trading.
For context: this is the highest quarterly PAT in the last 5 quarters on our records.
Management guided for a volume growth of 7-8% in FY27, with expectations to sustain EBITDA margins at FY26 equivalent levels. They are strategically expanding into new geographies like Jharkhand, Odisha, Northeast, and Bihar, and also focusing on developing adjacent, margin-accretive product categories such as blended
— This quarter: missed
Management's FY27 guidance (from the Q4 FY26 call) called for 7-8% volume growth and margins held at FY26-equivalent levels; this quarter met the margin promise but ran counter to the growth one, with revenue down rather than up. Management's press release attributes the softness to an extended heatwave, constrained LPG availability and Assembly-election-related disruptions, with the consumer-facing B2C business down a milder 4.1% YoY against a 17.9% YoY decline in B2B — framing this as a demand-environment issue rather than share loss, and rates its own performance as "neutral" even while keeping a bullish outlook. Corporate actions this quarter included board approval of a final dividend (record date August 14, 2026), appointment of KPMG as internal auditor and a new secretarial auditor for FY27, and continued on-market share purchases by the MD in June-July.
W1
Whether revenue/volume recovers toward management's 7-8% FY27 growth guidance after a 7.1% YoY decline this quarter
W2
Durability of the ~11% EBITDA margin once the finance-cost benefit from debt prepayment (Q1 interest cost ₹0.57 Cr vs ₹3.86 Cr YoY) fully annualizes
W3
Deployment of the remaining ₹46.51 Cr unutilised IPO proceeds, including ₹42.54 Cr earmarked for the Darjeeling gram-flour capacity expansion
Only one financial statement is presented (includes Ganesh ESOP/Employee Welfare Trust) — no separate consolidated section exists in this filing. No exceptional items in any period shown. PAT growth is dominated by an 85% YoY collapse in finance costs (₹3.86 Cr to ₹0.57 Cr) after ₹60 Cr of IPO proceeds were used to prepay borrowings, not by an accounting exceptional item.
Margin beat masks revenue miss; recovery pending H2
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Missed Q1 revenue guidance (-7.1% vs +7-8%); EBITDA beat likely temporary from commodity tailwinds.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 revenue missed guidance (-7.1% vs +7-8% target) but EBITDA margin expanded to record 11.2% (likely inflated by commodity tailwinds). Strategy sound but execution dependent on H2 recovery and new product success; capex delays add execution risk.
₹188.5 Cr
Revenue · −7.1% YoY₹12.5 Cr
Reported PAT · +31.4% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
Revenue declined 7.1% YoY amid heatwave, LPG shortage, elections, wheat prices
METDelivered result confirms ₹188.5Cr, down 7.1% YoY. Stated headwinds match external factors cited by management.
EBITDA margin expanded to 11.2%, highest in company history, up 66bps YoY
METDelivered OPM 11.2% confirmed; 66bps YoY improvement documented. Highest-ever status uncontradicted by any prior company data.
PAT grew 31.4% YoY to ₹12.5Cr driven by margin expansion and lower finance cost
METDelivered PAT ₹12.5Cr, +31.4% YoY matches exactly. Drivers (EBITDA expansion, lower finance cost) confirmed in financials.
Targeting 7-8% volume growth for full FY27 as per prior guidance
OVERSTATEDQ1 achieved -7.1% revenue growth. Full-year target still being chased but requires significant H2 recovery to succeed.
Earnings quality
What changed since the last call
Revenue growth trajectory
DowngradePrior 7-8% FY27 guidance; Q1 delivered -7.1%, requiring massive H2 recovery to achieve full-year target.
EBITDA margin guidance
NeutralPrior sustain FY26 levels (~9.8%); current 9.8-10% FY27. Maintained but Q1's 11.2% unsustainable without tailwinds.
Product mix evolution
UpgradeValue-added segment now 68% of B2C (vs 56% FY26), driven by Sattu; sweets, snacks, soya chunks planned Q3+.
Geographic expansion acceleration
UpgradeAdded 50+ distributors in Q1; targeting 300-400 over 2-3 years; non-WB revenue from 7-8% to 18-20%.
The Q&A
Analysts probed strategy constructively; management mostly direct. Some hedging on new category margins and TAM. Overall tone constructive, not aggressive.
Geographic expansion strategy — Rajesh Jain, RK Capital
AnsweredCurrently 7-8% from non-WB states; targeting 18-20% in 2-3 years. Planning 300-400 distributor additions across new geographies and products.
Product mix drivers — Nikhil, Ranga Investments
AnsweredValue-added segment (Sattu) performed strongly, raising its share within B2C. Overall B2C value-added now 68%.
Cost pass-through — Nikhil, Ranga Investments
AnsweredNo price increase; absorbed LPG cost through operational efficiency at plant and brand pull. Maintained consumer value.
Gross margin drivers — Divhy Gosar, Subhkam Ventures
AnsweredPrimarily product mix (value-added ~0.7-0.8%); minimal from RM softness. Better realization across categories was key driver.
Job work client disclosure — Rajesh Jain, RK Capital
PartialOne FMCG player only; cannot disclose due to confidentiality clause. Regional presence in areas where we operate.
Soya chunks ramp-up — Aarav, The Money Mart
AnsweredTargeting 2-3% of revenue over 2-3 years. Currently priced aggressively; expect to reach industry gross margin benchmark over 1.5-2 years.
Guidance
FY27 volume growth 7-8% (chasing)
MediumQ1 missed at -7.1%; dependent on major H2 recovery; better visibility after Q2.
FY27 EBITDA 9.8-10%
MediumAligns with sustaining FY26 levels (~9.8%); Q1's 11.2% likely inflated by commodity tailwinds.
Sattu/Besan facility FY27-28 commissioning
LowDelayed from original IPO timeline due to supply chain disruptions and geopolitical headwinds.
Risks the call surfaced
Revenue growth miss
HighQ1 revenue -7.1% vs guidance of 7-8% for full year. Requires major H2 recovery. FY27 target now heavily dependent on demand normalization and new product sales.
New product execution
MediumEthnic snacks, packaged sweets, soya chunks launching Q3/later; margins and volume uptake untested. Management declined to comment on margins ("too early").
Capex commissioning delay
MediumSattu and Besan facility (IPO-funded) commissioning pushed from original timeline to end of FY27-28. Due to supply chain disruptions and geopolitical headwinds.
Margin normalization risk
MediumQ1 EBITDA margin 11.2% inflated by favorable LPG and wheat prices. FY27 guidance at 9.8-10% signals expected margin compression as commodity tailwinds fade.
Eastern India concentration
MediumRevenue concentrated in Eastern India (primarily West Bengal); non-WB only 7-8%. Expansion to 18-20% is strategic but execution-dependent.
Management
Score 7/10. Direct on financials and strategy; some hedging on new category margins. Acknowledged Q1 miss clearly. Delivered margin expansion (11.2%) and +1% market share despite -7.1% revenue decline; strong cost control shown. Missed Q1 revenue guidance.
1 · Q2 FY27
Better visibility on recovery post-half-year results
2 · Q3 FY27
Ethnic snacks, packaged sweets launches; new category execution test
3 · FY27-28
Sattu/Besan facility commissioning; high-margin grain portfolio expansion
Strategy sound but execution dependent on H2 recovery and new product success; capex delays add execution risk.
Margin beat masks revenue miss — recovery thesis now on trial
Ganesh's EBITDA expanded to a record 11.2% despite a 7.1% revenue decline, but the margin beat is likely temporary. Management reiterated its 7–8% FY27 growth target, a claim the market immediately rejected.
₹12.5 Cr
+31.4% YoY
11.2%
+66bps YoY · highest ever
₹188.5 Cr
-7.1% YoY vs +7-8% FY27 guidance
9.8-10%
signals compression from Q1's 11.2%
On the headline, Q1 looks like a profit beat: PAT up 31.4% YoY to ₹12.5 crore, EBITDA margin at a record 11.2%. But the real story is a revenue miss that management is still chasing. Revenue came in at ₹188.5 crore, down 7.1% YoY—a significant miss against the 7–8% volume growth guidance for the full year. The market saw through the margin beat: the stock fell 1.1% on day 1, then 7.16% by day 3, and stayed down 6.9% by day 5. That sustained decline reflects the market's judgment that the revenue miss outweighs the margin beat.
Why the margin beat is likely one-quarter
Ganesh's EBITDA margin expanded to 11.2%, driven by three factors: product mix (value-added goods shifted from 56% to 68% of B2C revenue), cost control (LPG price increases were absorbed through operational efficiency), and favorable commodity pricing in wheat. But the company's own FY27 guidance—EBITDA margin of 9.8–10%—signals that management expects this margin to normalize. That 200–220 basis point compression from Q1's 11.2% to the full-year target is the company's own admission that Q1's tailwinds are temporary. When wheat and LPG prices normalize, the structural margin will be lower than what we see today.
Revenue declined 7.1% YoY due to heatwave, LPG shortage, elections, wheat price suppression
SupportedConfirmed: ₹188.5 Cr, -7.1% YoY. Cited headwinds align with external macro factors.
EBITDA margin expanded to 11.2%, highest in company history, +66bps YoY
SupportedConfirmed: 11.2% OPM delivered, +66bps YoY improvement documented.
PAT grew 31.4% YoY to ₹12.5 Cr driven by margin expansion and lower finance cost
SupportedConfirmed: ₹12.5 Cr, +31.4% YoY. Drivers (EBITDA expansion, lower finance cost) verified.
Still targeting 7–8% volume growth for full FY27 per prior guidance
OverstatedQ1 delivered -7.1% revenue growth. Full-year target requires massive H2 recovery; no evidence yet.
What changed on this quarter
Value-added product mix (B2C)
68% of revenue
Upgraded
56% of revenue
Distribution expansion
50+ added in Q1; tracking to target
On track
Target 300–400 distributors over 2–3 years
Non-West Bengal revenue
Targeting 18–20% in 2–3 years
Upgraded
7–8% of total
Sattu/Besan facility commissioning
Delayed to end of FY27–28 (supply chain, geopolitical headwinds)
Downgraded
IPO-funded, earlier in FY27
New product launches
Ethnic snacks soft-launch; sweets, soya chunks planned Q3+
Accelerated
Sattu live; masalas 6–7% of revenue
The bull-bear ledger
EBITDA margin expanded to record 11.2% on cost control and product mix discipline
Value-added products now 68% of B2C (vs 56%); structural margin support even without tailwinds
Market share gains (+1% wheat category) and distribution (+1% weighted) despite -7.1% revenue decline show brand strength
Strong balance sheet: ₹172 Cr net cash, ROCE 18%, ROE 13.3%; no solvency risk
Management executed cost control (absorbed LPG increases without price raise) and mix shift
Revenue miss of 7.1% YoY vs +7–8% FY27 guidance is critical; requires major H2 recovery to restore credibility
Q1 EBITDA 11.2% is likely unsustainable; company's own 9.8–10% FY27 guidance signals 200–220bps compression
New product execution untested: ethnic snacks, packaged sweets, soya chunks lack scale; margin trajectory unknown
Capex facility delay (now end of FY27–28) postpones high-margin grain portfolio expansion
FII outflow (−52bps QoQ to 2.26%); promoter increase (+157bps to 65.65%) signals insider conviction but foreign skepticism
How the street is positioned
The market's reaction was swift and brutal: the stock fell 7.16% by day 3 post-result and held that loss through day 5 (−6.9%). This was not a knee-jerk bounce-back; the decline sustained, telling us the market genuinely rejected the result despite the margin beat. The message: revenue miss > margin beat.
₹165.38
as of 2026-08-18
₹295.65
-44.06% from peak
₹152–₹295.65
Currently +8.8% off low, below all key SMAs (bearish)
₹204.94
Stock below long-term average
Valuation context is unforgiving. The stock is 44% below its all-time high and trading below its 20-day, 50-day, and 200-day moving averages (RSI 47.8, neutral but leaning bearish). This drawdown reflects accumulated skepticism—not just Q1, but the company's ability to deliver growth. FII holdings contracted by 52 basis points (from 2.78% to 2.26%) while promoter stake rose 157 basis points (to 65.65%). The divergence is telling: insiders are adding, but foreign investors are trimming. This is a classic signal of a stock whose growth narrative is in question.
Risks, ranked by severity for a holder
Revenue guidance credibility
High7–8% FY27 target is now heavily dependent on H2 recovery; Q1 miss of -7.1% means the full year requires roughly 9–10% growth in H2 to stay on track. No evidence yet that recovery is underway.
Margin normalization risk
HighQ1's 11.2% EBITDA inflated by favorable LPG/wheat pricing and product mix. Company's own 9.8–10% FY27 guidance signals 200–220bps compression when tailwinds fade. Margin sustainability is in question.
New product execution
MediumEthnic snacks, packaged sweets, soya chunks launching Q3+; none have scale or proven margin profiles. Management declined to comment on margins ('too early'). Execution risk is real.
Capex facility delay
MediumSattu/Besan plant commissioning now end of FY27–28 (vs. earlier expected). High-margin grain portfolio expansion is 12–18 months further out; timing and execution risk persist.
Eastern India concentration
Medium~92–93% revenue from West Bengal; non-WB only 7–8%. Geographic expansion to 18–20% is strategic but unproven. If Eastern India demand stays weak, core revenue headwind could persist.
Institutional outflow momentum
MediumFII trimmed 52bps QoQ amid -44% drawdown from ATH. If the growth miss persists, further foreign selling could accelerate the decline.
The debate
What to watch next
1 · Q2 FY27 revenue trajectory
Will be the key test. If revenue returns to mid-to-high single-digit growth (or better), the FY27 7–8% target becomes credible. If it stays flat or negative, the guidance miss is structural and not macro. This is the binary that determines the stock's direction.
2 · Product mix and margin progression
Track whether value-added products sustain their 68% B2C share and whether margins normalize gracefully to 9.8–10% (per guidance) or compress sharply. Early warning signs: if value-added share drops or margin deteriorates faster than guided.
3 · New product execution (Q3 onwards)
Ethnic snacks and packaged sweets launches in Q3 will show early adoption and margin realization. Soya chunks ramp will signal TAM and pricing power. Failure to launch at planned scale or margins below company expectations would be a major concern.
4 · Geographic expansion progress
Distributor additions and non-WB revenue traction. Are they on pace to hit 300–400 new distributors over 2–3 years? Is non-WB revenue progressing from 7–8% toward the 18–20% target? This determines long-term growth ceiling.
The number to track from here
Forget the 11.2% EBITDA margin for a moment. The single number that will determine whether Ganesh is a recovery or a structural miss is revenue growth. Q1 delivered -7.1% YoY. Q2 will tell us whether this is a one-quarter macro event (heatwave, elections, LPG) or a warning that the 7–8% FY27 guidance is unrealistic. If H2 shows a clear rebound—even to flat YoY—the stock has a road back. If H2 stays negative or barely positive, the credibility gap widens and the downside extends. For now, the stock is fairly valued as a hold-and-watch. The next two quarters are not about executing the strategy (the company is doing that); they're about proving the revenue math works.